Myrexis preclinical data

In mice bearing nicotinate phosphoribosyltransferase ( NAPRT1)-deficient pancreatic tumors, 75 mg/kg oral MPC-9528 on days 1, 10 and 19 inhibited tumor growth by 53% on day 19 vs. vehicle-treated con...